Alerts will be sent to your verified email
Verify Email
TAVERNIER
|
Eforu Entertainment
|
Biogen Pharmachem
|
Aeonx Digital Techno
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.15 % | 0.85 % | 5.98 % |
|
5yr average Equity Multiplier
|
1.35 | 1.01 | 1.3 |
|
5yr Average Asset Turnover Ratio
|
0.28 | 0.02 | 0.46 |
|
5yr Avg Net Profit Margin
|
196.82 % | -19.83 % | 10.23 % |
|
Price to Book
|
6.26 | 0.51 | 1.13 |
|
P/E
|
49.36 | 20.26 | 40.09 |
|
5yr Avg Cash Conversion Cycle
|
361.06 Days | 0.0 | -127.58 Days |
|
Inventory Days
|
0.0 | 0.0 | 7.24 Days |
|
Days Receivable
|
361.06 Days | 0.0 | 90.26 Days |
|
Days Payable
|
3.46 Days | 3.0 Days | 268.3 Days |
|
5yr Average Interest Coverage Ratio
|
73.81 | 902.8 | 19.33 |
|
5yr Avg ROCE
|
7.89 % | 0.2 % | 7.43 % |
|
5yr Avg Operating Profit Margin
|
0.53 % | -19.88 % | -3.29 % |
|
5 yr average Debt to Equity
|
0.32 | 0.0 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | -28.94 % | 3.44 % |
|
5yr Average Return on Assets
|
4.66 % | 0.19 % | 4.65 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.46 % | 0.0 | 54.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.81 % | 0.0 | -0.05 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Eforu Entertainment
|
Biogen Pharmachem
|
Aeonx Digital Techno
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|